ClinConnect ClinConnect Logo
Search / Trial NCT07042893

Effects of Pulmonary Resection on Right Ventricular Function

Launched by ÇAĞRI ÖZDEMIR · Jun 20, 2025

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Pulmonary Resection Right Ventricular Function Echocardiography Cardiothoracic Anesthesia

ClinConnect Summary

This clinical trial is studying how lung surgery affects the heart’s right side, specifically how well the right ventricle (one of the heart’s chambers) works after the operation. Since lung surgery can sometimes cause breathing and heart problems afterward, this study uses ultrasound tests of the heart (called echocardiography) before and after surgery to see if there are changes in heart function. The researchers are particularly looking at a measurement that combines blood pressure in the lungs and how well the right ventricle moves, to better understand how the heart handles the changes after lung surgery.

Adults between 18 and 80 years old who are scheduled for lung surgery and are generally in fair health may be eligible to join this study. However, people with irregular heartbeats, certain kidney problems, previous lung surgeries, recent heart attacks, or some lung function issues will not qualify. If you join, you can expect to have heart ultrasound scans before and after your surgery to monitor your heart’s function. This study aims to help doctors better predict and manage heart and lung complications after lung surgery, potentially improving recovery and long-term health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults aged 18 to 80 years
  • ASA classification I-III
  • Patients scheduled to undergo lung resection in thoracic surgery
  • Exclusion Criteria:
  • Patients with arrhythmia
  • Patients using antiarrhythmic drugs
  • Patients with renal failure requiring hemodialysis
  • Patients with a history of previous lung surgery
  • Patients with valvular heart disease
  • Patients with a history of angina pectoris or myocardial infarction within the past month
  • Patients with FEV1/FVC ratio below 60%

About çağrı özdemir

Çağrı Özdemir is a clinical trial sponsor dedicated to advancing medical research through the support and management of innovative clinical studies. Committed to upholding the highest standards of scientific integrity and patient safety, Çağrı Özdemir plays a pivotal role in facilitating the development of new treatments and therapies aimed at improving health outcomes.

Locations

Ankara, Yenimahalle, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported